Literature DB >> 30917288

Update in Cystic Fibrosis 2018.

Bonnie W Ramsey1,2,3, Gregory P Downey4,5,6,7,8, Christopher H Goss9,3,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30917288      PMCID： PMC6519861          DOI： 10.1164/rccm.201902-0310UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  68 in total

1.  Is Cystic Fibrosis-related Diabetes Reversible? New Data on CFTR Potentiation and Insulin Secretion.

Authors:  Andrew W Norris
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

2.  Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.

Authors:  Nicole Mayer-Hamblett; Margaret Rosenfeld; Julia Emerson; Christopher H Goss; Moira L Aitken
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

3.  Biomarkers: Their Role in CFTR Modulator Therapies from Early Development to the Clinic.

Authors:  Scott C Bell; Michelle E Wood
Journal:  Am J Respir Crit Care Med       Date:  2018-06-01       Impact factor: 21.405

4.  Additional 5' exons in the RGS3 locus generate multiple mRNA transcripts, one of which accounts for the origin of human PDZ-RGS3.

Authors:  John H Kehrl; Deepa Srikumar; Kathleen Harrison; Gaye L Wilson; Chong-Shan Shi
Journal:  Genomics       Date:  2002-06       Impact factor: 5.736

Review 5.  Innate and Adaptive Immunity in Cystic Fibrosis.

Authors:  Emanuela M Bruscia; Tracey L Bonfield
Journal:  Clin Chest Med       Date:  2015-12-28       Impact factor: 2.878

6.  Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.

Authors:  R William Vandivier; Valerie A Fadok; Peter R Hoffmann; Donna L Bratton; Churee Penvari; Kevin K Brown; Joseph D Brain; Frank J Accurso; Peter M Henson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

7.  Regulator of G-protein signaling 2 inhibits acid-induced mucin5AC hypersecretion in human airway epithelial cells.

Authors:  Chunyi Liu; Qi Li; Xiangdong Zhou; Victor P Kolosov; Juliy M Perelman
Journal:  Respir Physiol Neurobiol       Date:  2012-10-09       Impact factor: 1.931

8.  Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

Authors:  M W Konstan; K A Hilliard; T M Norvell; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

9.  Mucin Production and Hydration Responses to Mucopurulent Materials in Normal versus Cystic Fibrosis Airway Epithelia.

Authors:  Lubna H Abdullah; Raymond Coakley; Megan J Webster; Yunxiang Zhu; Robert Tarran; Giorgia Radicioni; Mehmet Kesimer; Richard C Boucher; C William Davis; Carla M P Ribeiro
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 30.528

10.  MicroRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia.

Authors:  Farruk Lutful Kabir; Namasivayam Ambalavanan; Gang Liu; Peng Li; George M Solomon; Charitharth V Lal; Marina Mazur; Brian Halloran; Tomasz Szul; William T Gerthoffer; Steven M Rowe; William T Harris
Journal:  Am J Respir Crit Care Med       Date:  2018-03-01       Impact factor: 30.528
View more
  3 in total

1.  Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.

Authors:  Jonas C Schupp; Sara Khanal; Jose L Gomez; Maor Sauler; Taylor S Adams; Geoffrey L Chupp; Xiting Yan; Sergio Poli; Yujiao Zhao; Ruth R Montgomery; Ivan O Rosas; Charles S Dela Cruz; Emanuela M Bruscia; Marie E Egan; Naftali Kaminski; Clemente J Britto
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

2.  Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.

Authors:  Aaron I Gardner; Iram J Haq; A John Simpson; Katrin A Becker; John Gallagher; Vinciane Saint-Criq; Bernard Verdon; Emily Mavin; Alexandra Trigg; Michael A Gray; Albert Koulman; Melissa J McDonnell; Andrew J Fisher; Elizabeth L Kramer; John P Clancy; Christopher Ward; Edward H Schuchman; Erich Gulbins; Malcolm Brodlie
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

3.  Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations.

Authors:  Clémence Martin; Théo Dhôte; Maha Zohra Ladjemi; Muriel Andrieu; Souganya Many; Vaarany Karunanithy; Frédéric Pène; Jennifer Da Silva; Pierre-Régis Burgel; Véronique Witko-Sarsat
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.